ストックスクリーナーアプリを入手
1.65
4.43%
0.07
アフターアワーズ：
1.65
前日終値:
$1.58
開ける：
$1.61
24時間の取引高:
1.35M
Relative Volume:
0.32
時価総額：
$407.30M
収益：
-
当期純損益:
$-283.26M
株価収益率:
-1.1224
EPS:
-1.47
ネットキャッシュフロー:
$-273.61M
1週間 パフォーマンス:
+7.84%
1か月 パフォーマンス:
-40.43%
6か月 パフォーマンス:
-59.36%
1年 パフォーマンス:
-80.02%
1日の値動き範囲:
$1.58
$1.66
1週間の範囲:
$1.49
$1.92
52週間の値動き範囲:
$1.26
$10.50
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.65 | 407.30M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - GlobeNewswire Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - PR Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Is Sana Biotechnology Inc. (NASDAQ:SANA) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Sana Biotechnology, Inc. Investors: Please contact the - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to - Bluefield Daily Telegraph
Investors in Sana Biotechnology, Inc. Should Contact The - GlobeNewswire
Shareholders That Lost Money on Sana Biotechnology, Inc. (SANA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - Eastern Progress
SANA Investors Have the Opportunity to Lead the Sana - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
KLP Kapitalforvaltning AS Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $10.80 Average PT from Brokerages - Defense World
Sana Biotechnology, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSANA - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - MarketScreener
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Morningstar
Lawsuit filed for Investors who lost money with shares of Sana Biotechnology, Inc. (NASDAQ: SANA) - openPR.com
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - markets.businessinsider.com
Robbins LLP Sues Sana Biotechnology for Misleading Investors - Lawyer Monthly
SANA Stockholders Should Contact Shareholder Rights Law - GlobeNewswire
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors - GlobeNewswire
Shareholders of Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - Finansavisen
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Sana Biotechnology, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the - GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit ... - Bluefield Daily Telegraph
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights – SANA - ACCESS Newswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
2.51%
大文字化:
|
ボリューム (24 時間):